Purple Biotech Ltd ADR
(PPBT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 06-2017 | 12-2016 | 06-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,000 | -6,010 | -12,120 | 0 | -4,200 |
| Depreciation Amortization | 4 | 2 | 2 | 0 | 1 |
| Other Working Capital | 120 | -900 | 260 | 0 | 280 |
| Other Operating Activity | 4,256 | 2,218 | 5,598 | 0 | 619 |
| Operating Cash Flow | $-8,620 | $-4,690 | $-6,260 | $0 | $-3,300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -3 | -10 | 0 | -9 |
| Net Acquisitions | -1,730 | -1,730 | 0 | 0 | 0 |
| Other Investing Activity | 4,510 | 363 | -7,890 | 0 | 0 |
| Investing Cash Flow | $2,770 | $-1,370 | $-7,900 | $0 | $-9 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 2,990 | -150 | 10,420 | 0 | 12,630 |
| Financing Cash Flow | $2,990 | $-150 | $10,420 | $0 | $12,630 |
| Exchange Rate Effect | 40 | -8 | -50 | 0 | -70 |
| Beginning Cash Position | 6,750 | 6,750 | 10,550 | 0 | 1,310 |
| End Cash Position | 3,940 | 520 | 6,750 | 0 | 10,550 |
| Net Cash Flow | $-2,810 | $-6,230 | $-3,800 | $0 | $9,240 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,620 | -4,690 | -6,260 | 0 | -3,300 |
| Free Cash Flow | -8,620 | -4,690 | -6,260 | 0 | -3,300 |